Asset write-downs
West Pharmaceutical Services Asset write-downs decreased by 95.9% to $300.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $300.00K to $300.00K. Over 4 years (FY 2021 to FY 2025), Asset write-downs shows an upward trend with a 20.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
High impairment charges suggest poor past investment decisions or deteriorating market conditions for specific business units.
Detailed definition
These are non-cash charges recognized when the carrying value of an asset exceeds its fair market value. They indicate t...
Peer comparison
Common in insurance and financial services during economic downturns; peers will report these when asset valuations decline.
operating_asset_impairment_chargesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.40M | $1.40M | $1.40M | $0.00 | $200.00K | $1.40M | $4.60M | $1.90M | $1.50M | $3.50M | $2.70M | $600.00K | $300.00K | $1.00M | $5.40M | $300.00K | $3.80M | $300.00K | $7.30M | $300.00K |
| QoQ Change | — | +0.0% | +0.0% | -100.0% | — | +600.0% | +228.6% | -58.7% | -21.1% | +133.3% | -22.9% | -77.8% | -50.0% | +233.3% | +440.0% | -94.4% | >999% | -92.1% | >999% | -95.9% |
| YoY Change | — | — | — | — | -85.7% | +0.0% | +228.6% | — | +650.0% | +150.0% | -41.3% | -68.4% | -80.0% | -71.4% | +100.0% | -50.0% | >999% | -70.0% | +35.2% | +0.0% |
Business Segments
| Segment | Q1 '23 |
|---|---|
| Proprietary Products | $9.40M |
| Total | $1.90M |
Proprietary Products was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
Asset write-downs at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's asset write-downs?
- West Pharmaceutical Services (WST) reported asset write-downs of $300.00K in Q1 2026.
- How has West Pharmaceutical Services's asset write-downs changed year-over-year?
- West Pharmaceutical Services's asset write-downs decreased by 0.0% year-over-year, from $300.00K to $300.00K.
- What is the long-term trend for West Pharmaceutical Services's asset write-downs?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's asset write-downs has grown at a 20.2% compound annual growth rate (CAGR), from $5.60M to $11.70M.
- What does asset write-downs mean?
- A write-down in the value of assets that are no longer worth as much as previously recorded.